Status:
NOT_YET_RECRUITING
Treatment Planning for ABA Employing Auxiliary Tools V2+ (TREAAT2+)
Lead Sponsor:
Montera Health Texas LLC
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
Technology enhancement in Applied Behavior Analysis (ABA) treatment planning may increase confidence, efficiency, consistency, and satisfaction for Board Certified Behavior Analysts (BCBAs) which, in ...
Detailed Description
Autism spectrum disorder (ASD) is a complex, heterogeneous neurodevelopmental disorder that accounts for \>$250 billion in direct and indirect annual expenditures and is estimated to occur in 1 out of...
Eligibility Criteria
Inclusion
- BCBAs will be eligible for enrollment if they are actively employed by Montera and are actively providing ABA treatment to Montera patients.
Exclusion
- BCBAs will be excluded from the study for one or more of the following reasons:
- BCBA requests that their data is not used in the study;
- BCBA does not complete the required assessments;
- BCBA does not have the aforementioned data required for inclusion.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06204536
Start Date
July 1 2025
End Date
June 30 2027
Last Update
November 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.